Pediatric liver transplantation;Pädiatrische lebertransplantation

Monatsschrift fur Kinderheilkunde

Volumn 160, Issue 4, 2012, Pages 343-357

  Melter, M ^a   Vermehren, J ^a   Grothues, D ^a   Knoppke, B ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Cholestasis; Liver diseases; Liver failure; Liver transplantation; Pediatrics

Indexed keywords

ADOLESCENT HEALTH; ADULTHOOD; ARTICLE; CHOLESTATIC CIRRHOSIS; END STAGE LIVER DISEASE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; KIDNEY DYSFUNCTION; LIVER CIRRHOSIS; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLIC DISORDER; PEDIATRIC SURGERY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863627010     PISSN: 00269298     EISSN: 14330474     Source Type: Journal    
DOI: 10.1007/s00112-011-2561-9     Document Type: Article

References (77)

1. Atkison P, Joubert G, Barron A et al (1995) Hypertrop-hic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet 345:894-896
2. Barama A, Perner F, Beauregard Zollinger L et al (2000) Absorption profiling of cyclosporin therapy for de novo kidney transplantation: a prospective randomized study comparing sparse sampling to trough monitoring. Transplantation 69:162
3. Bismuth H, Houssin D (1984) Reduced-sized ortho-topic liver graft in hepatic transplantation in children. Surgery 95:367-370 (Pubitemid 14195264)
4. Broelsch CE, Emond JC, Whitington PF et al (1990) Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 212:368-377 (Pubitemid 20289359)
5. Cacciarelli TV, Reyes J, Jaffe R et al (2001) Primary ta-crolimus (FK506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pe-diatric liver transplant recipients. Pediatr Transplant 5:359-364 (Pubitemid 32834804)
6. Calne R Y, Rolles K, White DJ et al (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2:1033-1036 (Pubitemid 10213970)
7. Campbel KM, Yazigi N, Ryckman FC et al (2006) High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 148:475-480
8. Cao S, Cox KL, Berquist W et al (1999) Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant 3:22-26 (Pubitemid 29234288)
9. Carpentier B, Gautier A, Legallais C (2009) Artificial and bioartificial liver devices: present and future. Gut 58:1690-1702
10. Cosimi AB, Cho SI, Delmonico FL et al (1987) A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation 43:91-95 (Pubitemid 17002463)
11. Couinaud C (1952) Hépatectomies gauches lobaires et segmentaires (etudes des conditions d'anatomi-ques). J Chir (Paris) 68:712
12. Couinaud C (1954) Anatomic principles of left and right regulated hepatectomy: technics. J Chir (Paris) 70:933-966
13. Cox KL, Lawrence Miyasaki LS, Garcia Kennedy R et al (1995) An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation 59:524-529
14. Faraj W, Dar F, Bartlet A et al (2010) Auxiliary liver transplantation for acute liver failure in children. Ann Surg 251:351-356
15. Fine RN (2002) Growth following solid-organ transplantation. Pediatr Transplant 6:47-52 (Pubitemid 34269736)
16. Fouquet V, Alves A, Branchereau S et al (2005) Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 11:152-160 (Pubitemid 40268212)
17. Ganschow R, Melter M, Wallot M et al (2007) Maintained efficiacy with steroid minimization in pediatric liver transplant recipients with basiliximab (simulect) induction therapy: a German multicenter randomized 12-month trial. Pediatr Transplant [Suppl 1] 11:36
18. Gilmour S, Adkins R, Liddel GA et al (2009) Assessment of psychoeducational outcomes after pediatric liver transplant. Am J Transplant 9:294-300
19. Goldstein G, Kremer AB, Barnes L, Hirsch RL (1987) OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients. J Pediatr 111:1046-1050 (Pubitemid 18024935)
20. Gregory CR, Huang X, Prat RE et al (1995) Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement. Transplantation 59:655-661
21. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K (1991) Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure: first successful case report. World J Surg 15:660-666
22. Jack T, Maecker B, Lehnhardt A et al (2003) Lympho-proliferative disorders in pediatric solid organ recipients: a retrospective analysis from the Medical School Hannover from 1990 to 2002. Nephrol Dial Transplant 18:828
23. Kelly DA (1997) Nutritional factors affecting growth before and after liver transplantation. Pediatr Transplant 1:80-84 (Pubitemid 127684811)
24. Kelly DA (2006) Current issues in pediatric transplantation. Pediatr Transplant 10:712-720 (Pubitemid 44186294)
25. Kelly D, Jara P, Rodeck B et al (2004) Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: randomised European multicentre trial. Lancet 364:1054-1061 (Pubitemid 39248664)
26. Knoppke B, Grothues D, Vermehren J et al (2011) Auxiliary liver transplantation in 2 children with acute liver failure. Transpl Int [Suppl 31] 24:40
27. Knoppke B, Vermehren J, Grothues D et al (2011) Auxiliary liver transplantation in a child with Crigler-Naj-jar-syndrome type I. Transpl Int [Suppl 31] 24:40
28. Kovarik JM, Gridelli BG, Martin S et al (2002) Basilixi-mab in pediatric liver transplantation: a pharmaco-kinetic-derived dosing algorithm. Pediatr Transplant 6:224-230 (Pubitemid 34836279)
29. Kuang AA, Rosenthal P, Roberts JP et al (1996) Decreased mortality from technical failure improves results in pediatric liver transplantation. Arch Surg 131:887-892
30. Levy GA, Lake JR, R. Beauregard Zollinger L et al (2000) Improved clinical outcomes for liver transplant recipients using cyclosporine blood level monitoring based on two-hour post-dose levels. Transplantation 69:387
31. McDiarmid SV (2000) Liver transplantation. The pedia-tric challenge. Clin Liver Dis 4:879-927
32. McDiarmid SV, Busuttil RW, Levy P et al (1991) The long-term outcome of OKT3 compared with cyclo-sporine prophylaxis after liver transplantation. Transplantation 52:91-97
33. McDiarmid SV, Busuttil RW, Ascher NL et al (1995) FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U. S. Multicenter Trial. Transplantation 59:530-536
34. McDiarmid SV, Gornbein JA, DeSilva PJ et al (1999) Factors affecting growth after pediatric liver transplantation. Transplantation 67:404-411 (Pubitemid 29094011)
35. Melter M (2007) Eingriffe auf spezielle Zentren be-schränken. Dtsch Ärztebl 104:A1-A7
36. Melter M (2012) Akutes Leberversagen. In: Rodeck B, Zimmer KP (Hrsg) Pädiatrische Gastroenterologie, He-patologie und Ernährung. Springer, Berlin Heidelberg New York
37. Melter M (2012) Immunsuppression. In: Rodeck B, Zimmer KP (Hrsg) Pädiatrische Gastroenterologie, He-patologie und Ernährung. Springer, Berlin Heidelberg New York
38. Melter M, Briscoe DM (2000) Challenges after pedia-tric transplantation. Semin Nephrol 20:199-208
39. Melter M, Rodeck B (1998) Sieben Jahre Erfahrung mit Prograf bei lebertransplantierten Kindern in Hannover. In: Burdelski M, Neuhaus P (Hrsg) Tacrolimus - Eine neue Standardtherapie in der Lebertransplanta-tion. Pabst, Lengerich, S 51-58
40. Melter M, Rodeck B, Kardorff R et al (1995) Liver transplantation for fulminant liver failure in childhood. Liver Transpl Surg [Suppl 1] 1:5
41. Melter M, Rodeck B, Kardorf R et al (1997) Pharmaco-kinetics of cyclosporine in pediatric long-term liver transplant recipients converted from Sandimmun to Neoral. Transpl Int 10:419-425 (Pubitemid 27494170)
42. Melter M, Nashan B, Strassburg A et al (2002) Die päd-iatrische Lebertransplantation - Indikationen und Er-gebnisse. TransplantLinc 4:54-62 (Pubitemid 36342404)
43. Melter M, Knoppke B, Grothues D, Schneble F (2010) Leber, Gallenwegsystem. In: Feldkamp A, Resch A (Hrsg) Pädiatrische Ultraschalldiagnostik. Ecomed Medizin, Heildelberg, S 1-36
44. Meyburg J, Schmidt J, Hoffman GF (2009) Liver cell transplantation in children. Clin Transplant [Suppl 21] 23:75-82
45. Mita MM, Mita A, Rowinsky EK (2003) The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther 2:169-177
46. Mohammad S, Alonso EM (2010) Approach to optimizing growth, rehabilitation, and neurodevelopmental outcomes in children after solid-organ transplantation. Pediatr Clin North Am 57:539-557
47. Morris RE, Huang X, Gregory CR et al (1995) Studies in experimental models of chronic rejection: use of ra-pamycin (sirolimus) and isoxazole derivatives (leflu-nomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Transplant Proc 27:2068-2069
48. Moukarzel AA, Najm I, Vargas J et al (1990) Effect of nutritional status on outcome of orthotopic liver transplantation in pediatric patients. Transplant Proc 22:1560-1563 (Pubitemid 20284442)
49. Moukarzel AA, Najm I, Vargas J et al (1990) Prediction of long-term linear growth following liver transplantation. Transplant Proc 22:1558-1559 (Pubitemid 20284441)
50. Ng VL, Alonso EM, Bucuvalas JC et al (2011) Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr Dec. 20. [Epub ahead of print]
51. Nielsen D, Briem-Richter A, Sornsakrin M et al (2011) The use of everolimus in pediatric liver transplant recipients: first experience in a single center. Pediatr Transplant 15:510-514
52. Ojo AO, Held PJ, Port FK et al (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349:931-940 (Pubitemid 37064766)
53. Pen I (1994) Posttransplant malignancies in pediatric organ transplant recipients. Transplant Proc 26:2763-2765
54. Pichlmayr R, Ringe B, Gubernatis G et al (1988) Transplantation einer Spenderleber auf zwei Empfänger (Splitting-Transplantation) - Eine neue Methode in der Weiterentwicklung der Lebersegmenttranplanta-tion. Langenbecks Arch Chir 373:127-130
55. Rauschenfels S, Grothues D, Vermehren J et al (2006) Autoantikörper nach pädiatrischer Lebertransplanta-tion. In: Melter M, Classen M (Hrsg) 21. Jahrestagung der Gesellschaft für pädiatrische Gastroenterologie und Ernährung (GPGE). sps Publications, Heilbronn, S 102
56. Rauschenfels S, Grothues D, Marquardt I et al (2009) Mycophenolate mofetil associated reversal of glome-rular filtration rate loss in liver transplanted children. J Pediatr Gastroenterol Nutr [Suppl 3] 48:E114-E115
57. Renz JF, Roos M de, Rosenthal P et al (2001) Posttrans-plantation growth in pediatric liver recipients. Liver Transpl 7:1040-1055 (Pubitemid 34023991)
58. Ringe H, Varnholt V, Zimmering M et al (2011) Continuous veno-venous single-pass albumin hemodiafil-tration in children with acute liver failure. Pediatr Crit Care Med 12:257-264
59. Rodeck B, Melter M, Hoyer PF et al (1994) Growth in long-term survivors after orthotopic liver transplantation in childhood. Transplant Proc 26:165-166 (Pubitemid 24080464)
60. Rodeck B, Melter M, Kardorf R et al (1996) Liver transplantation in children with chronic end stage liver disease: factors influencing survival after transplantation. Transplantation 62:1071-1076 (Pubitemid 26376654)
61. Rodeck B, Kardorf R, Melter M, Ehrich JHH (2000) Improvement of growth after growth hormone treatment in children who undergo liver transplantation. J Pediatr Gastroenterol Nutr 31:286-290
62. Schaefer B, Schaefer F, Engelman G et al (2011) Comparison of molecular adsorbents recirculating system (MARS) dialysis with combined plasma exchange and haemodialysis in children with acute liver failure. Ne-phrol Dial Transplant 26(11):3633-3639
63. Scheenstra R, Peeters PM, Verkade HJ, Gouw AS (2008) Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 49:880-886
64. Scientific Registry of Transplant Recipients (SRTR) (2006) Report 2006. SRTR, Minneapolis, http://www.srtr.org
65. Shanmugam N P, Dhawan A (2011) Selection criteria for liver transplantation in paediatric acute liver failure: the saga continues. Pediatr Transplant 15:5-6
66. Sokal EM, Antunes H, Beguin C et al (1997) Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 64:1438-1442 (Pubitemid 27513623)
67. Soltys KA, Mazariegos GV, Squires RH et al (2007) Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 7:2165-2171 (Pubitemid 47247040)
68. Starzl TE, Marchiora TL, Kaulla KN von et al (1963) Ho-motransplantation of the liver in humans. Surg Gyne-col Obstet 177:659-676
69. Starzl TE, Koep LJ, Schroter GP et al (1979) Liver replacement for pediatric patients. Pediatrics 63:825-829 (Pubitemid 9160869)
70. Starzl TE, Iwatsuki S, Van Thiel DH et al (1982) Evolution of liver transplantation. Hepatology 2:614-636 (Pubitemid 13173945)
71. Stewart SM, Uauy R, Kennard BD (1988) Mental development and growth in children with chronic liver disease of early and late onset. Pediatrics 82:167-172
72. Strassburg A, Pfister E, Arning A et al (2002) Basilixi-mab reduces acute liver allograft rejection in pediatric patients. Transplant Proc 34:2374-2375 (Pubitemid 35299788)
73. Thomson M, McKiernan P, Buckels J et al (1998) Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 26:478-481 (Pubitemid 28160703)
74. Ville Y, Fernandez H, Samuel D et al (1993) Pregnancy in liver transplant recipients: course and outcome in 19 cases. Am J Obstet Gynecol 168:896-902 (Pubitemid 23096016)
75. Wayman KI, Cox KL, Esteban A (1997) Neurodevelop-mental outcome of young children with extrahepatic biliary atresia 1 year after liver transplantation. J Pedi-atr 131:894-898 (Pubitemid 28027616)
76. Wiesner R, Edwards E, Freeman R et al (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124:91-96 (Pubitemid 36055342)
77. Younes BS, McDiarmid SV, Martin MG et al (2000) The effect of immunosuppression on posttransplant lym-phoproliferative disease in pediatric liver transplant patients. Transplantation 70:94-99 (Pubitemid 30490758)